| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
On January 16, 2025, the Company filed its Six Month Report with the Securities and Exchange Commission, and on the same day, t...
10-year renewable agreement to lease and operate existing milling facilityForafric Global PLC (NASDAQ:AFRI, or "Forafric...
U.S. stocks traded lower midway through trading, with Dow Jones dropping over 300 points on Tuesday. The Dow traded down 0.96%...
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge m...
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 1% on Friday.
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
